Filing Details

Accession Number:
0001140361-11-001960
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-01-07 17:15:58
Reporting Period:
2011-01-05
Filing Date:
2011-01-07
Accepted Time:
2011-01-07 17:15:58
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
880643 Genta Inc De GNTA Biological Products, (No Disgnostic Substances) (2836) 330326866
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1137918 M Lorettta Itri C/O Genta Incorporated
200 Connell Drive
Berkeley Heights NJ 07922
Pres R&D Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2011-01-05 3,455,617 $0.00 8,740,163 No 4 A Direct
Common Stock Disposition 2011-01-05 1,294,543 $0.02 7,445,620 No 4 S Direct
Common Stock Disposition 2011-01-06 2,161,074 $0.02 5,284,546 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 A Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Stock March 2010 Warrant Disposition 2011-01-05 4,073,381 $0.00 3,455,617 $0.00
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2010-03-09 2013-03-09 No 4 X Direct
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 1,121,476,596 Indirect By spouse
Footnotes
  1. Includes 3,455,617 shares of common stock held in Dr. Itri's IRA, 280,894 shares of common stock potentially issuable upon the vesting of currently outstanding restricted stock units held by Dr. Itri, 4,548,750 shares of common stock issuable upon the conversion of Senior Unsecured Convertible Promissory Notes due September 4, 2011, as amended (the Notes)and 454,902 shares of common stock issuable upon the exercise of the December 2010 warrant.
  2. Includes 768,817 shares of common stock issuable upon the vesting of currently outstanding restricted stock units of Dr. Itri's spouse, Dr. Warrell, 551,770,303 shares of common stock issuable upon the conversion of the Notes held by Dr. Warrell, 3,032,500 shares of common stock issuable upon the conversion of Notes held by Dr. Warrell's IRA, 509,350,729 shares of common stock issuable upon the exercise of the March 2010 Warrant held in joint name with Dr. Warrell, 56,250,980 shares of common stock issuable upon the exercise of the December 2010 Warrant held in joint name with Dr. Warrell and 303,267 shares of common stock issuable upon the exercise of the December 2010 Warrant held by Dr. Warrell's IRA.